Krsnaa DiagnosticsNSE:KRSNAA -1.75%75 Gross Margin % is 69.53% as of Mar. 2026, which is 7% above its 10-year median of 64.86. GuruFocus rates NSE:KRSNAA with a GF Score™ of 75/100 and a GF Value™ of ₹902.48 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 196 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks better than 72.45% on this metric.
The historical rank and industry rank for Krsnaa Diagnostics's Gross Margin % or its related term are showing as below:
NSE:KRSNAA'
s Gross Margin % Range Over the Past 10 Years
Min: 51.58 Med: 64.86 Max: 68.85
Current: 68.85
During the past 8 years, the highestGross Margin % of Krsnaa Diagnostics was 68.85%. The lowest was 51.58%. And the median was 64.86%.
NSE:KRSNAA's Gross Margin % is ranked better than 72.45% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.14
vs NSE:KRSNAA: 68.85
Krsnaa Diagnostics had a gross margin of 69.53% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Krsnaa Diagnostics was 4.80% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Krsnaa Diagnostics had a gross margin of 69.53% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Krsnaa Diagnostics Gross Margin % Related Terms
Krsnaa Diagnostics Gross Margin % Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KRSNAA vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Krsnaa Diagnostics (NSE:KRSNAA) has a Gross Margin % of 69.53% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Krsnaa Diagnostics and its competitors. This is near median its historical median of 64.86. Over the past decade, Krsnaa Diagnostics' Gross Margin % has ranged from 51.58 to 68.85. According to the industry distribution chart, Krsnaa Diagnostics ranks #54 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 27.6%.
Is Krsnaa Diagnostics' Gross Margin % too high?
Krsnaa Diagnostics' current Gross Margin % of 69.53% is near median its 10-year median of 64.86. Over the past 10 years, this metric has ranged from a low of 51.58 to a high of 68.85. The Medical Diagnostics & Research industry median Gross Margin % is 51.14. Krsnaa Diagnostics' value of 69.53% is 36% above this industry median. Based on the distribution chart, Krsnaa Diagnostics ranks #54 out of 196 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #54 out of 196 companies for Gross Margin %. This puts Krsnaa Diagnostics in the upper half of its industry. The industry median Gross Margin % is 51.14. Krsnaa Diagnostics' value of 69.53% is 36% above this benchmark. Historically, Krsnaa Diagnostics' own Gross Margin % has ranged from 51.58 to 68.85 over the past decade. While the company's 10-year median is 64.86 vs. the industry median of 51.14, Krsnaa Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.14, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krsnaa Diagnostics's current Gross Margin % of 69.53% is 36% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current Gross Margin % is 69.53%, which is near median its own 10-year median of 64.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹902.48, compared to a current price of ₹562.85 — trading 37.6% below its estimated fair value. The current Gross Margin % is 69.53%, which is near median its 10-year median of 64.86 and 36% above the Medical Diagnostics & Research industry median of 51.14. Krsnaa Diagnostics' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Gross Margin % is 69.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹562.85 is trading 37.6% below its estimated GF Value™ of ₹902.48.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
Gross Margin %: 69.53% (near median its 10-year median of 64.86)
GF Value™: ₹902.48 vs. price of ₹562.85 (37.6% below fair value)
Industry Position: 36% above the Medical Diagnostics & Research median (#54 of 196)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
75GF Score
Get the complete analysis for NSE:KRSNAA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
